ECSP992840A - PROCEDURE TO TREAT HEART FAILURE - Google Patents

PROCEDURE TO TREAT HEART FAILURE

Info

Publication number
ECSP992840A
ECSP992840A ECSP992840A ECSP992840A EC SP992840 A ECSP992840 A EC SP992840A EC SP992840 A ECSP992840 A EC SP992840A EC SP992840 A ECSP992840 A EC SP992840A
Authority
EC
Ecuador
Prior art keywords
heart failure
procedure
treat heart
phenoxy
trimethyl
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Yuhpyng Liang Chen
Anthony Andrea Fossa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP992840 priority Critical patent/ECSP992840A/en
Publication of ECSP992840A publication Critical patent/ECSP992840A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Esta invención se refiere a un procedimiento para el tratamiento de un mamífero que presenta insuficiencia cardiaca, que comprende administrar a un mamifero una cantidad terapéuticamente eficaz de 4-(1-etil-propoxi)-3,6-dimeti-2(2,4,6-trimetil-fenoxi)-piridina y (3,6 dimetil-2-(2,4,6 -trimetil-fenoxil-)-piridin-4-il)-(1-etil-propil)-amina o una sal farmacéuticamente aceptable de las mismas. Esta invención también se refiere a procedimientos para usar combinaciones de esos dos agentes con otros compuestos para el tratamiento de la isuficiencia cardiaca congestiva para tratar la insuficiencia cardiaca congestiva.This invention relates to a method of treating a mammal presenting with heart failure, comprising administering to a mammal a therapeutically effective amount of 4- (1-ethyl-propoxy) -3,6-dimethi-2 (2,4 , 6-trimethyl-phenoxy) -pyridine and (3,6-dimethyl-2- (2,4,6 -trimethyl-phenoxy -) - pyridin-4-yl) - (1-ethyl-propyl) -amine or a salt pharmaceutically acceptable thereof. This invention also relates to methods for using combinations of those two agents with other compounds for the treatment of congestive heart failure to treat congestive heart failure.

ECSP992840 1999-01-26 1999-01-26 PROCEDURE TO TREAT HEART FAILURE ECSP992840A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP992840 ECSP992840A (en) 1999-01-26 1999-01-26 PROCEDURE TO TREAT HEART FAILURE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP992840 ECSP992840A (en) 1999-01-26 1999-01-26 PROCEDURE TO TREAT HEART FAILURE

Publications (1)

Publication Number Publication Date
ECSP992840A true ECSP992840A (en) 1999-05-17

Family

ID=42043830

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP992840 ECSP992840A (en) 1999-01-26 1999-01-26 PROCEDURE TO TREAT HEART FAILURE

Country Status (1)

Country Link
EC (1) ECSP992840A (en)

Similar Documents

Publication Publication Date Title
BR9900653A (en) Method for treating heart failure
EA200300155A1 (en) THERAPEUTIC COMBINATION OF THE CETR AND ATORVASTATIN INHIBITOR
EA200100573A1 (en) APPLICATION OF CYCLOOXIGENASE-2 INHIBITOR, MATRIC METALLOPROTEINASE INHIBITOR, ANTI-TUMOR MEDICINE, AND OPTIONAL IRRADIATION AS A COMBINED METHOD OF TREATING THE NEO.
AR013742A1 (en) METHOD FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA WITH NON-SUBSTITUTED POLIDIALILAMINE
LU91928I2 (en) Ipilimumab and its pharmaceutically acceptable derivatives (YERVOY®)
DK0740650T3 (en) Codrugs as a method of controlled drug transport
DK1346041T3 (en) Therapeutic agents and methods for their use in the treatment of an amyloidogenic disease
BR9811099A (en) Urokinase inhibitors
CY1109191T1 (en) A NEW USE OF DIFFERIPRON
MY119375A (en) Treatment of tinnitus using neuroprotective agents
DK0950057T3 (en) 3-pyridylene enantiomers and their use as analgesics
EA199800717A1 (en) METHOD FOR THE TREATMENT OF MAMMAL DISEASES AND THE CYVITTERION COMPOSITION
DK1237562T3 (en) Process for the preparation of micania extracts containing micanolide and dihydromycanolide and use in the treatment of proliferative diseases
DK0799618T3 (en) Use of alpha1 adrenoreceptor antagonists in the manufacture of a drug for the prevention and treatment of cancer
ECSP992840A (en) PROCEDURE TO TREAT HEART FAILURE
NO20032006D0 (en) Use of melagatran for the manufacture of a medicament for the treatment of ischemic disorders
WO2001034546A3 (en) Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
ES2186153T3 (en) SULFATE 5-ALFA-PREGNAN-3-BETA-OL-20-ONA FOR THE TREATMENT OF TUMORS AND CNS DISORDERS.
EP1143996A4 (en) Method of treating chronic cardiac disease
NO20091111L (en) Use of R (+) - alpha- (2,3-dimethoxyphenyl) -1- [2- (4-fluorophenyl) ethyl] -4-piperidine-methanol for the treatment of sleep disorders
ATE268170T1 (en) USE OF SUMMERIC ACID OR SALTS THEREOF TO TREAT INSULIN RESISTANCE
DE69734349D1 (en) TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN
MX9604692A (en) Quinoxaline derivatives for treating tinnitus.
GT200100066A (en) HYPERTENSIVE AGENT AND ITS USE.
EA199800820A1 (en) METHOD OF TREATING ABUSE OF MEDICINES